関連する実験動画
Updated: Dec 29, 2025
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.7K
AMPK-カスパース6軸は,非アルコール性脂肪肝炎における肝損傷を制御する
Peng Zhao1, Xiaoli Sun2, Cynthia Chaggan2
1Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. asaltiel@ucsd.edu pez021@ucsd.edu.
Science (New York, N.Y.)
|February 8, 2020
まとめ
非アルコール性脂肪肝炎 (NASH) では,抑制されたアデノシンモノフォスファート (AMP) 活性化タンパク質キナーゼ (AMPK) がカスパース-6の活性化を可能にし,肝臓細胞死を引き起こす. AMPKの回復やカスパース6の抑制は,NASHの進行を緩和する.
科学分野:
- ヘパトロジー
- 分子生物学
- 生物化学
背景:
- 非アルコール性脂肪肝炎 (NASH) では肝細胞死が重要である.
- アデノシン・モノフォスファート (AMP) 活性化タンパク質キナーゼ (AMPK) は,NASHで減少しています.
- AMPK欠乏症はNASHモデルで肝損傷を悪化させる.
研究 の 目的:
- NASHにおける肝細胞死亡の調節におけるAMPK-カスパース-6軸の役割を調査する.
- AMPKやカスパース6を標的とした治療戦略をNASH治療で探求する.
主な方法:
- NASHのマウスモデルを使用しました.
- カスパース6を含む,研究されたAMPK活性とその下流標的.
- AMPKの活性化とカスパース6の阻害が肝臓損傷と線維症に及ぼす影響を評価した.
主要な成果:
- AMPKは通常酸化し,プロアポプトシスカスパース6を阻害し,肝細胞のアポプトシスを防ぐ.
- NASHにおけるAMPK抑制はカスパース6の活性化につながり,肝臓細胞死亡を促進します.
- 活性カスパース6はBidを割って,シトクロームcの放出と細胞死亡のフィードフォワードループを誘導する.
- AMPKの活性化やカスパース6の阻害は,NASH発症後でも,肝臓損傷や線維症を改善しました.
結論:
- AMPK-カスパース6信号経路は,NASHにおける肝細胞死亡の重要な調節因子である.
- AMPKまたはカスパース6を標的とした治療は,NASHとその付随する肝臓損傷の管理に有望な治療法です.
関連する概念動画
01:24Caspases
13.5K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.5K
01:25cAMP-dependent Protein Kinase Pathways
8.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.1K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
130
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
130
01:22PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
01:24Liver Regeneration
4.1K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
01:20The JAK-STAT Signaling Pathway
11.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.6K